Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD.

Hans-Joachim Schmoll,Alexander Stein,Eric Van Cutsem,Timothy J. Price,Ralf Hofheinz,Bernard Nordlinger,Jean-François Daisne,Jos Janssens,Baruch Brenner,H. Reinel,Stephan Hollerbach,Karel Caca,F. Fauth,Carla Hannig,John Zalcberg,Niall C. Tebbutt,Murielle Mauer,Sandrine Marreaud,Manfred P. Lutz,Karin Haustermans

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD.

2020

PURPOSEThe PETACC 6 trial investigates whether the addition of oxaliplatin to preoperative capecitabine-based chemoradiation and postoperative capecitabine improves disease-free survival (DFS) in l...

Keywords:

Colorectal cancer
Oncology
Internal medicine
locally advanced
Medicine
Oxaliplatin
Capecitabine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations